Abstract：
:Balhimycin, a vancomycin-type glycopeptide, is a lipid II targeting antibiotic produced by Amycolatopsis balhimycina. A. balhimycina has developed a self-resistance mechanism based on the synergistic action of different enzymes resulting in modified peptidoglycan. The canonical resistance mechanism against glycopeptides is the synthesis of peptidoglycan precursors ending with acyl-d-alanyl-d-lactate (d-Ala-d-Lac) rather than acyl-d-alanyl-d-alanine (d-Ala-d-Ala). This reprogramming is the result of the enzymes VanH, VanA, and VanX. VanH and VanA are required to produce d-Ala-d-Lac; VanX cleaves cytosolic pools of d-Ala-d-Ala, thereby ensuring that peptidoglycan is enriched in d-Ala-d-Lac. In A. balhimycina, the ΔvanHAXAb mutant showed a reduced glycopeptide resistance in comparison to the wild type. Nevertheless, ΔvanHAXAb was paradoxically still able to produce d-Ala-d-Lac containing resistant cell wall precursors suggesting the presence of a novel alternative glycopeptide resistance mechanism. In silico analysis, inactivation studies, and biochemical assays led to the characterization of an enzyme, Ddl1Ab, as a paraloguous chromosomal d-Ala-d-Lac ligase able to complement the function of VanAAb in the ΔvanHAXAb mutant. Furthermore, A. balhimycina harbors a vanYAb gene encoding a d,d-carboxypeptidase. Transcriptional analysis revealed an upregulated expression of vanYAb in the ΔvanHAXAb mutant. VanYAb cleaves the endstanding d-Ala from the pentapeptide precursors, reducing the quantity of sensitive cell wall precursors in the absence of VanXAb. These findings represent an unprecedented coordinated layer of resistance mechanisms in a glycopeptide antibiotic producing bacterium.
journal_name
ACS Infect Disjournal_title
ACS infectious diseasesauthors
Frasch HJ,Kalan L,Kilian R,Martin T,Wright GD,Stegmann Edoi
10.1021/acsinfecdis.5b00011subject
Has Abstractpub_date
2015-06-12 00:00:00pages
243-52issue
6issn
2373-8227journal_volume
1pub_type
杂志文章abstract：:Each year, infectious diseases are responsible for millions of deaths, most of which occur in the rural areas of developing countries. Many of the infectious disease diagnostic tools used today require a great deal of time, a laboratory setting, and trained personnel. Due to this, the need for effective point-of-care ...
journal_title：ACS infectious diseases
pub_type： 杂志文章,评审
doi：10.1021/acsinfecdis.8b00023
更新日期：2018-08-10 00:00:00
abstract：:The α-Gal antigen [Galα(1,3)Galβ(1,4)GlcNAcα] is an immunodominant epitope displayed by infective trypomastigote forms of Trypanosoma cruzi, the causative agent of Chagas disease. A virus-like particle displaying a high density of α-Gal was found to be a superior reagent for the ELISA-based serological diagnosis of Ch...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.6b00114
更新日期：2016-12-09 00:00:00
abstract：:Amonabactins are a group of four related catecholate siderophores produced by several species of the genus Aeromonas, including A. hydrophila and the fish pathogen A. salmonicida subsp. salmonicida. Although the gene cluster encoding amonabactin biosynthesis also contains a gene that could encode the ferri-siderophore...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00274
更新日期：2019-11-08 00:00:00
abstract：:Bacterial quorum sensing (QS) is being contemplated as a promising target for developing innovative diagnostic and therapeutic strategies. Here we report for the first time the development of antibodies against 2-heptyl-4-quinolone (HHQ), a signaling molecule from the pqs QS system of Pseudomonas aeruginosa, involved ...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.0c00604
更新日期：2020-12-11 00:00:00
abstract：:The Burkholderia cepacia complex is a group of Gram-negative bacteria that are opportunistic pathogens in immunocompromised individuals, such as those with cystic fibrosis (CF) or chronic granulomatous disease (CGD). Burkholderia are intrinsically resistant to many antibiotics and the lack of antibiotic development ne...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.7b00235
更新日期：2018-05-11 00:00:00
abstract：:Pandemics such as influenza, smallpox, and plague have caused the loss of hundreds of millions of lives and have occurred for many centuries. Fortunately, they have been largely eliminated by the use of vaccinations and drugs. More recently, Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (M...
journal_title：ACS infectious diseases
pub_type： 历史文章,杂志文章,评审
doi：10.1021/acsinfecdis.0c00291
更新日期：2020-07-10 00:00:00
abstract：:MmpL3, an essential mycolate transporter in the inner membrane of Mycobacterium tuberculosis (Mtb), has been identified as a target of multiple, chemically diverse antitubercular drugs. However, several of these molecules seem to have secondary targets and inhibit bacterial growth by more than one mechanism. Here, we ...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.0c00675
更新日期：2021-01-08 00:00:00
abstract：:The current explosive epidemic of Zika virus in South and Central America, as well as the Caribbean, poses a global public health emergency. Here we comment on the challenges on development of better diagnosis and potential therapeutics and vaccine for Zika virus. ...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.6b00030
更新日期：2016-03-11 00:00:00
abstract：:In December 2019, a novel beta (β) coronavirus eventually named SARS-CoV-2 emerged in Wuhan, Hubei province, China, causing an outbreak of severe and even fatal pneumonia in humans. The virus has spread very rapidly to many countries across the world, resulting in the World Health Organization (WHO) to declare a pande...
journal_title：ACS infectious diseases
pub_type： 杂志文章,评审
doi：10.1021/acsinfecdis.0c00274
更新日期：2020-09-11 00:00:00
abstract：:Marburg virus causes sporadic outbreaks of severe hemorrhagic fever with high case fatality rates. Approved, effective, and safe therapeutic or prophylactic countermeasures are lacking. To address this, we used phage display to engineer a synthetic antibody, sFab H3, which binds the Marburg virus VP35 protein (mVP35)....
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00091
更新日期：2019-08-09 00:00:00
abstract：:Bacterial sliding clamps control the access of DNA polymerases to the replication fork and are appealing targets for antibacterial drug development. It is therefore essential to decipher the polymerase-clamp binding mode across various bacterial species. Here, two residues of the E. coli clamp binding pocket, EcS346 a...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00089
更新日期：2019-06-14 00:00:00
abstract：:Computer-aided screening of antimicrobial peptides (AMPs) is a promising approach for discovering novel therapies against multidrug-resistant bacterial infections. Here, we functionally and structurally characterized an Escherichia coli-derived AMP (EcDBS1R5) previously designed through pattern identification [α-helic...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.8b00219
更新日期：2018-12-14 00:00:00
abstract：:RNA-dependent RNA polymerases (RdRPs) from nonsegmented negative strand (NNS) RNA viruses perform both mRNA transcription and genome replication, and these activities are regulated by their interactions with RNA and other accessory proteins within the ribonucleoprotein (RNP) complex. Detailed biochemical characterizat...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.0c00554
更新日期：2020-10-09 00:00:00
abstract：:Three O. volvulus immunogenic peptide sequences recently discovered by peptide microarray were adapted to a lateral flow assay (LFA). The LFA employs gold nanoshells as novel high-contrast reporter nanoparticles and detects a serological response against the 3 peptides, found in OvOC9384, OvOC198, and OvOC5528, respec...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.8b00031
更新日期：2018-06-08 00:00:00
abstract：:In order to identify the most attractive starting points for drugs that can be used to prevent malaria, a diverse chemical space comprising tens of thousands to millions of small molecules may need to be examined. Achieving this throughput necessitates the development of efficient ultra-high-throughput screening metho...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.5b00143
更新日期：2016-04-08 00:00:00
abstract：:Malaria remains a major global health problem. In 2015 alone, more than 200 million cases of malaria were reported, and more than 400,000 deaths occurred. Since 2010, emerging resistance to current front-line ACTs (artemisinin combination therapies) has been detected in endemic countries. Therefore, there is an urgenc...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.7b00211
更新日期：2018-04-13 00:00:00
abstract：:Dysentery is a major health threat that dramatically impacts childhood morbidity and mortality in developing countries. Various pathogenic agents cause dysentery, such as Shigella spp. and Escherichia coli, which are very closely related if not identical species. Sensitive and precise detection and identification of t...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00199
更新日期：2019-11-08 00:00:00
abstract：:Brain-eating amoebae cause devastating infections in the central nervous system of humans, resulting in a mortality rate of 95%. There are limited effective therapeutic options available clinically for treating granulomatous amoebic encephalitis and primary amoebic meningoencephalitis caused by Acanthamoeba castellani...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00263
更新日期：2019-12-13 00:00:00
abstract：:Quaternary ammonium compounds (QACs) have historically served as a first line of defense against pathogenic bacteria. Recent reports have shown that QAC resistance is increasing at an alarming rate, especially among methicillin-resistant Staphylococcus aureus (MRSA), and preliminary work has suggested that the number ...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.5b00032
更新日期：2015-07-10 00:00:00
abstract：:Clostridioides difficile (C. difficile) infection (CDI) is the primary cause of nosocomial antibiotic-associated diarrhea, with high recurrence rates following initial antibiotic treatment regimens. Restoration of the host gut microbiome through probiotic therapy is under investigation to reduce recurrence. Current in...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00415
更新日期：2020-05-08 00:00:00
abstract：:Malaria continues to be a significant cause of death and morbidity worldwide, and there is a need for new antimalarial drugs with novel targets. We have focused as a potential target for drug development on N-myristoyl transferase (NMT), an enzyme that acylates a wide range of substrate proteins. The NMT substrates in...
journal_title：ACS infectious diseases
pub_type： 杂志文章,评审
doi：10.1021/acsinfecdis.7b00203
更新日期：2018-04-13 00:00:00
abstract：:Recent epidemiological studies have revealed that Porphyromonas gingivalis, a major pathogen in periodontal disease, is associated with the development of oral squamous cell carcinoma (OSCC). However, the underlying mechanisms induced by P. gingivalis have not been well-defined. We aimed to determine the role of P. gi...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00032
更新日期：2019-08-09 00:00:00
abstract：:A method for the fast isolation, propagation, and characterization of very low count bacteriophages active against pathogenic bacterial strains is described in this study. Bacteriophages with a count of 102 phage particles were dynamically adhered from the maximum 10 mL blood plasma sample onto the nanostructured part...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.0c00358
更新日期：2020-10-09 00:00:00
abstract：:In this study, we describe a simple and rapid antibacterial susceptibility testing (AST) method for Staphylococcus aureus called S. aureus specific fluorescence resonance energy transfer (FRET) probe-based AST (SF-AST), which is based on an S. aureus specific FRET probe (SF probe) that detects micrococcal nuclease (MN...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00260
更新日期：2020-02-14 00:00:00
abstract：:In response to the urgent need for new antibiotic development strategies, antimicrobial peptides and their synthetic mimetics are being investigated as promising alternatives to traditional antibiotics. To facilitate their development into clinically viable candidates, we need to understand what molecular features and...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.8b00079
更新日期：2018-08-10 00:00:00
abstract：:MurG (uridine diphosphate-N-acetylglucosamine/N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase) is an essential bacterial glycosyltransferase that catalyzes the N-acetylglucosamine (GlcNAc) transformation of lipid I to lipid II during peptidoglycan biosynthesis. Park's nucleot...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.9b00242
更新日期：2020-06-12 00:00:00
abstract：:Chronic hepatitis B virus (HBV) infection remains a major cause of morbidity and mortality worldwide. HBV surface antigen loss is considered a functional cure and is an ideal goal for antiviral therapy. However, current treatment regimens, including nucleos(t)ide analogues or interferons monotherapy and combination th...
journal_title：ACS infectious diseases
pub_type： 杂志文章,评审
doi：10.1021/acsinfecdis.8b00297
更新日期：2019-05-10 00:00:00
abstract：:The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-...
journal_title：ACS infectious diseases
pub_type： 杂志文章,评审
doi：10.1021/acsinfecdis.0c00052
更新日期：2020-05-08 00:00:00
abstract：:Antibiotic resistance can come at a high cost, both in terms of fitness for the pathogen and poorer outcomes for patients. The fitness landscape encountered by bacterial pathogens varies greatly throughout patient populations in terms of host immunity as well as the duration and spectrum of antibiotics encountered. Se...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.8b00158
更新日期：2018-09-14 00:00:00
abstract：:The envelope glycoprotein (Env) enables HIV-1 cell entry through fusion of host-cell and viral membranes induced by the transmembrane subunit gp41. Antibodies targeting the C-terminal sequence of the membrane-proximal external region (C-MPER) block the fusogenic activity of gp41 and achieve neutralization of divergent...
journal_title：ACS infectious diseases
pub_type： 杂志文章
doi：10.1021/acsinfecdis.0c00243
更新日期：2020-08-14 00:00:00
